1244-58-2 Usage
Description
Cannabidiolic acid (Item No. 18090) is a certified reference material categorized as a phytocannabinoid. Cannabidiolic acid is produced by the oxidocyclization of cannabigerolic acid (Item Nos. 20019 | 9001574) by cannabidiolic acid synthase. This product is intended for research and forensic applications.
Uses
Cannabidiolic Acid is a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Cannabidiolic Acid offers potential therapeutic value in the abrogation of
cancer cell migration and aggressive breast cancers.
Definition
ChEBI: A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a 3-p-mentha-1,8-dien-3-yl (limonene) group.
Check Digit Verification of cas no
The CAS Registry Mumber 1244-58-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,4 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1244-58:
(6*1)+(5*2)+(4*4)+(3*4)+(2*5)+(1*8)=62
62 % 10 = 2
So 1244-58-2 is a valid CAS Registry Number.
InChI:InChI=1/C22H30O4/c1-5-6-7-8-15-12-18(23)20(21(24)19(15)22(25)26)17-11-14(4)9-10-16(17)13(2)3/h11-12,16-17,23-24H,2,5-10H2,1,3-4H3,(H,25,26)/t16-,17+/m0/s1
1244-58-2Relevant articles and documents
CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF
-
Paragraph 00409, (2021/02/26)
The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a tetrahydrocann
CANNABIDIOLIC ACID ESTERS FOR TREATING MUSCULAR DYSTROPHY
-
Page/Page column 40; 41, (2021/07/10)
The present invention provides compositions and methods for treating muscular dystrophy. In particular, the present invention provides pharmaceutical compositions and formulations comprising a cannabidiolic acid (CBDA) ester alone or in combination with o
CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF
-
Page/Page column 50-51, (2021/12/31)
The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.